Randomized, placebo-controlled trial of rofecoxib in the acute treatment of migraine

Neurology

Volumn 62, Issue 9, 2004, Pages 1552-1557

  Silberstein, S ^a,h   Tepper, S ^c   Brandes, J ^d   Diamond, M ^e   Goldstein, J ^f   Winner, P ^g   Venkatraman, S ^b   Vrijens, F ^b   Malbecq, W ^b   Lines, C ^b   Visser, W H ^b   Reines, S ^b   Yuen, E ^b  

^a JEFFERSON HEADACHE CENTER   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

^c NEW ENGLAND CENTER FOR HEADACHE   (United States)

^d Nashville Neuroscience Group   (United States)

^e DIAMOND HEADACHE CLINIC   (United States)

^f San Francisco Clinical Research Center   (United States)

^g Premiere Res Inst P Beach Neurol   (United States)

^h THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2 INHIBITOR; PLACEBO; ROFECOXIB;

ADULT; ANALGESIA; ARTICLE; ASTHENIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISABILITY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG HALF LIFE; DRUG TOLERABILITY; DYSPEPSIA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE; NAUSEA; PARESTHESIA; PHOBIA; PHONOPHOBIA; PHOTOPHOBIA; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SOMNOLENCE; XEROSTOMIA;

EID: 2342661139     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000123260.61631.C4     Document Type: Article

References (17)

1. Silberstein SD. Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review). Neurology 2000;55:754-763.
2. Sheftell FD. Advances in headache: role and impact of over-the-counter medications in the management of headache. Neurol Clin 1997; 15:187-198.
3. Matchar DB, Young WB, Rosenberg JH, et al. Evidence-based guidelines for migraine headache in the primary care setting: pharmacological management of acute attacks. American Academy of Neurology 2000 (http://www.aan.com/professionals/practice/guidelines.cfm).
4. Merck & Co., Inc. VIOXX (rofecoxib tablets and oral suspension). In: Physicians' desk reference. Montvale, NJ: Thomson PDR, 2003:2120-2125.
5. Morrison BW, Fricke J, Brown J, Yuan W, Kotey P, Mehlisch D. The optimal analgesic dose of rofecoxib: overview of six randomized controlled trials. JADA 2000;131:1729-1737.
6. Morrison BW, Daniels SE, Kotey P, Cantu N, Seidenberg B. Rofecoxib, a specific cyclooxygenase-2 inhibitor, in primary dysmenorrhea: a randomized controlled trial. Obstet Gynecol 1999;94:504-508.
7. Reicin A, Brown J, Jove M, et al. Efficacy of single-dose and multidose rofecoxib in the treatment of post-orthopedic surgery pain. Am J Orthop 2001;30:40-48.
8. Chang DJ, Fricke JR, Bird SR, Bohidar NR, Dobbins TW, Geba GP. Rofecoxib versus codeine/acetaminophen in postoperative dental pain: a double-blind, randomized, placebo- and active comparator-controlled clinical trial. Clin Ther 2001;23:1446-1455.
9. Fricke J, Vassil T, Kotey P, Reicin AS, Korn S. Rofecoxib compared to oxycodone/acetaminophen for postoperative dental pain. Ann Rheum Dis 2002;61(suppl 1):128-129.
10. Chang DJ, Desjardins PJ, Black P, et al. Comparison of rofecoxib and multiple doses of the opioid oxycodone/paracetamol for the management of acute pain. Ann Rheum Dis 2003;62(suppl 1):301.
11. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988;8(suppl 7):9-96.
12. Santanello NC, Hartmaier SL, Epstein RS, Silberstein SD. Validation of a new quality of life questionnaire for acute migraine headache. Headache 1995;35:330-337.
13. O'Brien P. Procedures for comparing samples with multiple endpoints. Biometrics 1984;40:1079-1087.
14. Gail M, Simon R. Testing for qualitative interactions between treatment effects and patient subsets. Biometrics 1985;41:361-372.
15. Ferrari MD, Loder E, McCarroll KA, Lines CR. Meta-analysis of rizatriptan efficacy in randomized controlled clinical trials. Cephalalgia 2001;21:129-136.
16. Lipton RB, Stewart WF, von Korff M. Burden of migraine: societal costs and therapeutic opportunities. Neurology 1997;48(suppl 3):S4-S9.
17. Davies GM, Santanello N, Lipton R. Determinants of patient satisfaction with migraine therapy. Cephalalgia 2000;20:554-560.